mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.04 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |